Immunogenicity of a Fourth Homologous Dose of NVX-CoV2373

被引:15
作者
Alves, Katia [1 ]
Plested, Joyce S. [1 ]
Galbiati, Shirley [1 ]
Chau, Gordon [1 ]
Cloney-Clark, Shane [1 ]
Zhu, Mingzhu [1 ]
Kalkeri, Raj [1 ]
Patel, Nita [1 ]
Smith, Kathy [1 ]
Marcheschi, Alex [1 ]
Pfeiffer, Susan [1 ]
McFall, Heather [1 ]
Smith, Gale [1 ]
Glenn, Gregory M. [1 ]
Dubovsky, Filip [1 ]
Mallory, Raburn M. [1 ]
机构
[1] Novavax, Gaithersburg, MD 20878 USA
关键词
D O I
10.1056/NEJMc2215509
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fourth Dose of SARS-CoV-2 Adjuvanted Protein VaccineBoosters of adjuvanted NVX-CoV2373 protein vaccine led to increasing neutralizing titers of antibody specific for the ancestral strain and omicron variants. Whether the elicited antibodies protect against infection is unclear.
引用
收藏
页码:857 / 859
页数:3
相关论文
共 5 条
[1]  
Glenn GM., 2022, VACCINES RELATED BIO
[2]   Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation [J].
Huang, Yunda ;
Borisov, Oleg ;
Kee, Jia Jin ;
Carpp, Lindsay N. ;
Wrin, Terri ;
Cai, Suqin ;
Sarzotti-Kelsoe, Marcella ;
McDanal, Charlene ;
Eaton, Amanda ;
Pajon, Rolando ;
Hural, John ;
Posavad, Christine M. ;
Gill, Katherine ;
Karuna, Shelly ;
Corey, Lawrence ;
McElrath, M. Juliana ;
Gilbert, Peter B. ;
Petropoulos, Christos J. ;
Montefiori, David C. .
SCIENTIFIC REPORTS, 2021, 11 (01)
[3]   Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial [J].
Mallory, Raburn M. ;
Formica, Neil ;
Pfeiffer, Susan ;
Wilkinson, Bethanie ;
Marcheschi, Alex ;
Albert, Gary ;
McFall, Heather ;
Robinson, Michelle ;
Plested, Joyce S. ;
Zhu, Mingzhu ;
Cloney-Clark, Shane ;
Zhou, Bin ;
Chau, Gordon ;
Robertson, Andreana ;
Maciejewski, Sonia ;
Hammond, Holly L. ;
Baracco, Lauren ;
Logue, James ;
Frieman, Matthew B. ;
Smith, Gale ;
Patel, Nita ;
Glenn, Gregory M. .
LANCET INFECTIOUS DISEASES, 2022, 22 (11) :1565-1576
[4]   Improved Titers against Influenza Drift Variants with a Nanoparticle Vaccine [J].
Shinde, Vivek ;
Fries, Louis ;
Glenn, Gregory M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (24) :2346-2348
[5]  
van der Straten K., 2022, MEDRXIV, DOI [10.1101/2022.01.03.21268582v1, DOI 10.1101/2022.01.03.21268582V1]